NO914085D0 - Hepatospesifikke insulinanaloger - Google Patents

Hepatospesifikke insulinanaloger

Info

Publication number
NO914085D0
NO914085D0 NO1991914085A NO914085A NO914085D0 NO 914085 D0 NO914085 D0 NO 914085D0 NO 1991914085 A NO1991914085 A NO 1991914085A NO 914085 A NO914085 A NO 914085A NO 914085 D0 NO914085 D0 NO 914085D0
Authority
NO
Norway
Prior art keywords
hepatospecific
insulin analogs
insulin analogues
hepatospecific insulin
insulin
Prior art date
Application number
NO1991914085A
Other languages
English (en)
Other versions
NO914085L (no
NO301544B1 (no
Inventor
Panayotis Katsoyannis
Original Assignee
Mount Sinai School Of Medicin
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mount Sinai School Of Medicin filed Critical Mount Sinai School Of Medicin
Publication of NO914085D0 publication Critical patent/NO914085D0/no
Publication of NO914085L publication Critical patent/NO914085L/no
Publication of NO301544B1 publication Critical patent/NO301544B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
NO914085A 1989-04-20 1991-10-17 Analogifremgangsmåte for fremstilling av en insulinanalog NO301544B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US34092989A 1989-04-20 1989-04-20
PCT/US1990/002070 WO1990012814A1 (en) 1989-04-20 1990-04-17 Hepatospecific insulin analogues

Publications (3)

Publication Number Publication Date
NO914085D0 true NO914085D0 (no) 1991-10-17
NO914085L NO914085L (no) 1991-11-28
NO301544B1 NO301544B1 (no) 1997-11-10

Family

ID=23335524

Family Applications (1)

Application Number Title Priority Date Filing Date
NO914085A NO301544B1 (no) 1989-04-20 1991-10-17 Analogifremgangsmåte for fremstilling av en insulinanalog

Country Status (15)

Country Link
EP (1) EP0469084B1 (no)
JP (1) JPH04504858A (no)
AT (1) ATE120762T1 (no)
AU (1) AU631868B2 (no)
CA (1) CA2014896A1 (no)
DE (1) DE69018461T2 (no)
FI (1) FI914898A0 (no)
GR (1) GR1000908B (no)
HU (1) HU210142B (no)
IE (1) IE67353B1 (no)
IL (1) IL94163A (no)
NO (1) NO301544B1 (no)
PT (1) PT93832B (no)
WO (1) WO1990012814A1 (no)
ZA (1) ZA902965B (no)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK158390D0 (da) * 1990-07-02 1990-07-02 Novo Nordisk As Nye peptider
DK33591D0 (no) * 1991-02-27 1991-02-27 Novo Nordisk As
US5268453A (en) * 1991-08-08 1993-12-07 Scios Inc. Tissue-selective insulin analogs
GB9316895D0 (en) * 1993-08-13 1993-09-29 Guy S And St Thomas Hospitals Hepatoselective insulin analogues
US5915378A (en) * 1993-01-29 1999-06-29 Aradigm Corporation Creating an aerosolized formulation of insulin
US6131567A (en) * 1993-01-29 2000-10-17 Aradigm Corporation Method of use of monomeric insulin as a means for improving the reproducibility of inhaled insulin
US5970973A (en) * 1993-01-29 1999-10-26 Aradigm Corporation Method of delivering insulin lispro
US5873358A (en) * 1993-01-29 1999-02-23 Aradigm Corporation Method of maintaining a diabetic patient's blood glucose level in a desired range
US6024090A (en) 1993-01-29 2000-02-15 Aradigm Corporation Method of treating a diabetic patient by aerosolized administration of insulin lispro
US5743250A (en) 1993-01-29 1998-04-28 Aradigm Corporation Insulin delivery enhanced by coached breathing
US5888477A (en) * 1993-01-29 1999-03-30 Aradigm Corporation Use of monomeric insulin as a means for improving the bioavailability of inhaled insulin
TW360548B (en) * 1993-04-08 1999-06-11 Powderject Res Ltd Products for therapeutic use
US6342225B1 (en) 1993-08-13 2002-01-29 Deutshces Wollforschungsinstitut Pharmaceutical active conjugates
US6933272B1 (en) 1998-09-22 2005-08-23 Erik Helmerhorst Use of non-peptidyl compounds for the treatment of insulin related ailments
AUPP609198A0 (en) * 1998-09-22 1998-10-15 Curtin University Of Technology Use of non-peptidyl compounds for the treatment of insulin related ailments
EP1174437A4 (en) 1999-04-26 2006-03-15 Ajinomoto Kk HORMONAL INHIBITOR STIMULATING MELANOCYTES
US7597884B2 (en) 2004-08-09 2009-10-06 Alios Biopharma, Inc. Hyperglycosylated polypeptide variants and methods of use
WO2006019015A1 (ja) * 2004-08-18 2006-02-23 Kaneka Corporation インスリン結合たんぱく質と結合能力のあるペプチドおよび吸着材
WO2007020256A1 (en) 2005-08-16 2007-02-22 Novo Nordisk A/S Method for making mature insulin polypeptides
HUE029512T2 (en) 2006-09-22 2017-03-28 Novo Nordisk As Protease Resistant Insulin Analogs
JP5503968B2 (ja) 2006-09-27 2014-05-28 ノボ・ノルデイスク・エー／エス 成熟インスリンポリペプチドの作製方法
US20110065633A1 (en) 2008-01-30 2011-03-17 Indiana University Research And Technology Corporation Ester-based peptide prodrugs
WO2009112583A2 (en) 2008-03-14 2009-09-17 Novo Nordisk A/S Protease-stabilized insulin analogues
WO2009115469A1 (en) 2008-03-18 2009-09-24 Novo Nordisk A/S Protease stabilized, acylated insulin analogues
CN102245633A (zh) * 2008-12-09 2011-11-16 诺沃—诺迪斯克有限公司 新的胰岛素类似物
CA2744558A1 (en) 2008-12-19 2010-07-15 Indiana University Research And Technology Corporation Amide-based insulin prodrugs
JP5789515B2 (ja) 2008-12-19 2015-10-07 インディアナ ユニバーシティー リサーチ アンド テクノロジー コーポレーションＩｎｄｉａｎａ Ｕｎｉｖｅｒｓｉｔｙ Ｒｅｓｅａｒｃｈ Ａｎｄ Ｔｅｃｈｎｏｌｏｇｙ Ｃｏｒｐｏｒａｔｉｏｎ インスリン類似体
AU2011268327B2 (en) 2010-06-16 2016-02-25 Indiana University Research And Technology Corporation Single chain insulin agonists exhibiting high activity at the insulin receptor
EP2585102B1 (en) 2010-06-24 2015-05-06 Indiana University Research and Technology Corporation Amide-based insulin prodrugs
WO2013096386A1 (en) 2011-12-20 2013-06-27 Indiana University Research And Technology Corporation Ctp-based insulin analogs for treatment of diabetes
JP6387008B2 (ja) 2012-09-26 2018-09-05 インディアナ ユニバーシティー リサーチ アンド テクノロジー コーポレーションＩｎｄｉａｎａ Ｕｎｉｖｅｒｓｉｔｙ Ｒｅｓｅａｒｃｈ Ａｎｄ Ｔｅｃｈｎｏｌｏｇｙ Ｃｏｒｐｏｒａｔｉｏｎ インスリンアナローグダイマー
US9670162B2 (en) 2013-03-14 2017-06-06 The Board Of Trustees Of The Leland Stanford Junio Mitochondrial aldehyde dehyrogenase-2 modulators and methods of use thereof
RU2678134C2 (ru) 2013-03-14 2019-01-23 Индиана Юниверсити Рисерч Энд Текнолоджи Корпорейшн Конъюгаты инсулин-инкретин
WO2015052088A1 (en) 2013-10-07 2015-04-16 Novo Nordisk A/S Novel derivative of an insulin analogue
EP3206710B1 (en) 2014-09-24 2020-05-06 Indiana University Research & Technology Corporation Incretin-insulin conjugates
ES2947409T3 (es) 2014-09-24 2023-08-08 Univ Indiana Res & Tech Corp Profármacos de insulina a base de amida lipídica
HRP20221324T1 (hr) 2016-12-16 2022-12-23 Novo Nordisk A/S Farmaceutski pripravci koji sadrže inzulin

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH25772A (en) * 1985-08-30 1991-10-18 Novo Industri As Insulin analogues, process for their preparation

Also Published As

Publication number Publication date
JPH04504858A (ja) 1992-08-27
EP0469084B1 (en) 1995-04-05
IE67353B1 (en) 1996-03-20
EP0469084A1 (en) 1992-02-05
NO914085L (no) 1991-11-28
GR1000908B (el) 1993-03-16
HU210142B (en) 1995-02-28
DE69018461T2 (de) 1995-08-03
IL94163A (en) 1995-08-31
DE69018461D1 (de) 1995-05-11
PT93832A (pt) 1990-11-20
HUT59941A (en) 1992-07-28
IE901404L (en) 1990-10-20
NO301544B1 (no) 1997-11-10
ZA902965B (en) 1991-02-27
FI914898A0 (fi) 1991-10-17
HU903398D0 (en) 1991-12-30
IL94163A0 (en) 1991-01-31
WO1990012814A1 (en) 1990-11-01
PT93832B (pt) 1996-09-30
CA2014896A1 (en) 1990-10-20
AU5541590A (en) 1990-11-16
AU631868B2 (en) 1992-12-10
GR900100290A (en) 1991-09-27
ATE120762T1 (de) 1995-04-15

Similar Documents

Publication Publication Date Title
NO914085L (no) Hepatospesifikke insulinanaloger
NZ506447A (en) Peptide analogues of insulin with alanine substitutions and pharmaceutical use
ES552093A0 (es) Un procedimiento para sintetizar una secuencia de aminoacidos que contienen la totalidad o parte de la secuencia de aminoacidos de la preprorrelaxina -h2 humana.
ATE266043T1 (de) Peptidanaloge des menschlichen basischen myelinproteins
DK81583A (da) Derivater af 3-hydroxysmoersyre og fremgangsmaade til fremstilling deraf
PT88086A (pt) Processo para a preparacao de composicoes farmaceuticas a base de sais de alfa-aminoacidos basicos e de alfa-ceto-analogos de aminoacidos de cadeia ramificada apropriadas para o tratamento da uremia
ES2056431T3 (es) Procedimiento para la produccion de r(+)-aminocarnitina y s(-)-aminocarnitina.
SE7501342L (no)
GR890100827A (el) Μέ?οδος παραγωγής παραγώγων τετραπεπτιδίων ως ανταγωνιστών CCK.
PT78046B (de) Cyclische peptide mit somatostatin-wirkung
FI942392A (fi) Peptidejä ja vasta-aineita nivelreuman hoitoon
ES2124954T3 (es) Ciclohexapeptidos y sus mezclas, procedimiento para su preparacion asi como su empleo.
ATE92078T1 (de) Pharmakologisch aktive peptide.
PT99850A (pt) Processo para a preparacao de novos peptideos com efeito insulinico
PL292414A1 (en) Method of obtaining complexes containing s-(+)-phenylalcanic and -hydroxyalcanic acids
ATE98962T1 (de) Menschliche rhinoviruspeptide.
DK0423326T3 (da) Hidtil ukendt fysiologisk aktivt peptid og calcium-metabolisme-regulerende middel, der omfatter peptidet som effektiv besta
DK119391A (da) Humaninsulinanaloger
JPS53132539A (en) Protected amino acid or peptide having said protected amino acid residue
ATE92772T1 (de) Patch fuer eingeweidechirurgie.